Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.

Niemantsverdriet E, Goossens J, Struyfs H, Martin J-J, Goeman J, De Deyn PPaul, Vanderstichele H, Engelborghs S
J Alzheimers Dis. 2016; 51(1):97-106. PMID: 26836187. Abstract